Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|July 2, 1998
A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in childrenS P Lowis, L Price, A D Pearson, et al.
Biochemical Pharmacology|October 15, 1987
The effect of the anthrapyrazole antitumour agent CI941 on rat liver microsome and cytochrome P-450 reductase mediated free radical processes. Inhibition of doxorubicin activation in vitroM A Graham, D R Newell, J Butler, et al.
British Journal of Cancer|March 15, 2012
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibitionE J Haagensen, S Kyle, G S Beale, et al.
Magnetic Resonance in Medicine|January 1, 1991
19F nuclear magnetic resonance imaging of drug distribution in vivo: the disposition of an antifolate anticancer drug in miceR J Maxwell, T A Frenkiel, D R Newell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and ratsD I Jodrell, D R Newell, W Gibson, et al.
Seminars in Oncology|December 22, 1999
Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell linesP G Smith, E Marshman, A H Calvert, et al.
Biochemical Pharmacology|February 28, 2001
Hypoxanthine transport in human tumour cell lines: relationship to the inhibition of hypoxanthine rescue by dipyridamoleE Marshman, G A Taylor, H D Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapyM J Tilby, D R Newell, C Viner, et al.
British Journal of Cancer|November 11, 1999
Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeuticsD R Newell, S S Burtles, B W Fox, et al.
British Journal of Cancer|November 1, 1990
Pharmacokinetic studies with the antifolate C2-desamino-C2-methyl-N10-propargyl-2'-trifluoromethyl-5,8-dideazafolic acid (CB3988) in mice and rats using in vivo 19F-NMR spectroscopyD R Newell, R J Maxwell, G M Bisset, et al.
Pageof 12